Company page

Protokinetix, Inc.

Protokinetix, Inc. (PKTX) is a public company based in the United States with a market capitalization of approximately $2.5 million. The company focuses on developing innovative therapies and technologies. Protokinetix aims to advance its research and product offerings in the biotechnology sector.

PKTX:OTCUpdated July 24, 2026
Protokinetix, Inc. logo
Ticker
PKTX:OTC
Asset type
Stock
Market cap
$2.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD